Last Updated on Mar 12, 2016

Latest Publications and Research on Congo Fever

J. Virol.  2020 Jan 29  

Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.

Mishra AK, Moyer CL, Abelson DM, Deer DJ, El Omari K, Duman R, Lobel L, Lutwama JJ, Dye JM, Wagner A, Chandran K, Cross RW, Geisbert TW, Zeitlin L, Bornholdt ZA, McLellan JS

Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of the most widespread tick-borne viral infection in humans. CCHFV encodes a secr... Read More

Source: PubMed


Antiviral Res.  2020 Jan 22  

The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Zivcec M, Spiropoulou CF, Spengler JR

For more than 20 years, researchers have used laboratory mice lacking type I or both type I and II interferon (IFN) responses to study high-containmen... Read More

Source: PubMed

Vaccines (Basel)    

Being Pregnant during the Kivu Ebola Virus Outbreak in DR Congo: The rVSV-ZEBOV Vaccine and Its Accessibility by Mothers and Infants during Humanitarian Crises and in Conflict Areas.

Schwartz DA

The Ebola virus disease (EVD) outbreak that began in Kivu province of the Democratic Republic of the Congo (DRC) in July 2018 is the second largest in... Read More

Source: PubMed

Euro Surveill.    

The cost of insecurity: from flare-up to control of a major Ebola virus disease hotspot during the outbreak in the Democratic Republic of the Congo, 2019.

Jombart T, Jarvis CI, Mesfin S, Tabal N, Mossoko M, Mpia LM, Abedi AA, Chene S, Forbin EE, Belizaire MRD, de Radiguès X, Ngombo R, Tutu Y, Finger F, Crowe M, Edmunds WJ, Nsio J, Yam A, Diallo B, Gueye AS, Ahuka-Mundeke S, Yao M, Fall IS

The ongoing Ebola outbreak in the eastern Democratic Republic of the Congo is facing unprecedented levels of insecurity and violence. We evaluate the ... Read More

Source: PubMed

Malar. J.    

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.

Massamba L, Madamet M, Benoit N, Chevalier A, Fonta I, Mondain V, Jeandel PY, Amalvict R, Delaunay P, Mosnier J, Marty P, Pomares C, Pradines B

The drug combination atovaquone-proguanil, is recommended for treatment of uncomplicated falciparum malaria in France. Despite high efficacy, atovaquo... Read More

Source: PubMed

Most Popular on Medindia